Thermo Fisher Scientific Inc (TMO) Shares Sold by Signature Estate & Investment Advisors LLC

Signature Estate & Investment Advisors LLC reduced its holdings in Thermo Fisher Scientific Inc (NYSE:TMO) by 3.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 92,211 shares of the medical research company’s stock after selling 3,590 shares during the quarter. Thermo Fisher Scientific comprises 1.9% of Signature Estate & Investment Advisors LLC’s portfolio, making the stock its 16th biggest holding. Signature Estate & Investment Advisors LLC’s holdings in Thermo Fisher Scientific were worth $17,446,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of TMO. BlackRock Inc. lifted its stake in shares of Thermo Fisher Scientific by 2,692.1% in the first quarter. BlackRock Inc. now owns 22,988,885 shares of the medical research company’s stock valued at $3,531,095,000 after buying an additional 22,165,530 shares during the period. Capital Research Global Investors lifted its stake in shares of Thermo Fisher Scientific by 29.8% in the second quarter. Capital Research Global Investors now owns 17,304,897 shares of the medical research company’s stock valued at $3,019,185,000 after buying an additional 3,973,136 shares during the period. Janus Henderson Group PLC lifted its stake in shares of Thermo Fisher Scientific by 2,058.1% in the second quarter. Janus Henderson Group PLC now owns 2,342,046 shares of the medical research company’s stock valued at $408,620,000 after buying an additional 2,233,522 shares during the period. Veritas Asset Management LLP lifted its stake in shares of Thermo Fisher Scientific by 112.4% in the second quarter. Veritas Asset Management LLP now owns 2,430,759 shares of the medical research company’s stock valued at $424,095,000 after buying an additional 1,286,259 shares during the period. Finally, Harbour Capital Advisors LLC lifted its stake in shares of Thermo Fisher Scientific by 18,197.5% in the second quarter. Harbour Capital Advisors LLC now owns 1,201,051 shares of the medical research company’s stock valued at $6,884,000 after buying an additional 1,194,487 shares during the period. 86.16% of the stock is currently owned by institutional investors.

Thermo Fisher Scientific Inc (TMO) traded down $10.17 on Tuesday, reaching $182.03. 3,926,700 shares of the company traded hands, compared to its average volume of 1,555,471. The company has a market cap of $77,071.31, a PE ratio of 21.12, a P/E/G ratio of 1.76 and a beta of 1.06. Thermo Fisher Scientific Inc has a 1-year low of $139.88 and a 1-year high of $201.20. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, beating the consensus estimate of $2.24 by $0.07. The business had revenue of $5.12 billion for the quarter, compared to analysts’ expectations of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The firm’s revenue was up 13.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.03 EPS. equities research analysts predict that Thermo Fisher Scientific Inc will post 9.36 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be given a $0.15 dividend. The ex-dividend date is Thursday, December 14th. This represents a $0.60 annualized dividend and a yield of 0.33%. Thermo Fisher Scientific’s dividend payout ratio is currently 10.19%.

In related news, CEO Marc N. Casper sold 50,000 shares of the business’s stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $188.39, for a total value of $9,419,500.00. Following the sale, the chief executive officer now directly owns 252,577 shares of the company’s stock, valued at approximately $47,582,981.03. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.49% of the company’s stock.

A number of research analysts have commented on TMO shares. Argus restated a “buy” rating on shares of Thermo Fisher Scientific in a research note on Tuesday, August 22nd. They noted that the move was a valuation call. Cowen restated a “buy” rating and set a $200.00 price target on shares of Thermo Fisher Scientific in a research note on Friday, September 1st. Morgan Stanley reiterated an “overweight” rating and issued a $220.00 target price on shares of Thermo Fisher Scientific in a research note on Wednesday, September 6th. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 target price for the company in a research note on Thursday, September 7th. Finally, Barclays reaffirmed an “overweight” rating and set a $215.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a report on Monday, September 25th. One research analyst has rated the stock with a hold rating and sixteen have given a buy rating to the company. Thermo Fisher Scientific currently has an average rating of “Buy” and a consensus price target of $205.21.

TRADEMARK VIOLATION WARNING: “Thermo Fisher Scientific Inc (TMO) Shares Sold by Signature Estate & Investment Advisors LLC” was reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://www.chaffeybreeze.com/2017/12/05/thermo-fisher-scientific-inc-tmo-shares-sold-by-signature-estate-investment-advisors-llc.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply